The Biden administration on Tuesday named the first 10 medicines that will be subject to price negotiations between Medicare and participating drug companies.
Aug 29, 2023
0
1
The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just a few years ago, a pair of recent ...
Aug 24, 2023
1
99
In trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making ...
Aug 17, 2023
3
117
The BMJ's editor-in-chief is urging the Academy of Medical Royal Colleges and its members to establish a standard for declaring payments they receive from industry and patient groups in the wake of a recent investigation ...
Aug 16, 2023
0
1
The headlines surrounding a new class of weight-loss drugs fluctuate like a patient stepping on and off a scale.
Aug 10, 2023
0
3
Kentucky's 2007 lawsuit against Purdue Pharma marked a major turn in the opioid crisis. It was the first time a member of the Sackler family, who owned Purdue, was deposed about the company's role in the opioid epidemic. ...
Aug 3, 2023
0
21
Cancer research centers conducting clinical trials could enroll more patients from underrepresented racial and ethnic groups by placing greater emphasis on relieving investigators of the costs of translating consent documents ...
Aug 2, 2023
0
75
While demand for prescription stimulants is surging, a shortage of the drugs persists, so federal officials have stepped in and asked drug companies to ramp up production of the medications.
Aug 2, 2023
0
1
In 2016, recognizing that lack of research in female animals was hampering the success of treatments for mood disorders, the National Institutes of Health (NIH) changed its policy for basic research to include sex as a biological ...
Aug 1, 2023
0
23
An anti-inflammatory drug commonly used to treat gout could significantly improve outcomes in patients with mild-to-moderate COVID-19 infections, according to research by a team led by University of Georgia professor Ralph ...
Jul 27, 2023
0
38
